J Biol Chem, Vol. 273, Issue 29, 18015-18018, July 17, 1998
COMMUNICATION
Characterization of the Human Analogue of a Scrapie-responsive
Gene
Michel
Dron
,
Françoise
Dandoy-Dron
,
Frédéric
Guillo
,
Louisa
Benboudjema
,
Jean-Jacques
Hauw¶,
Pierre
Lebon
,
Dominique
Dormont**, and
Michael G.
Tovey
From the
Laboratory of Viral Oncology CNRS UPR 9045, IFC1, 94801 Villejuif cedex, France, the ¶ Laboratoire de
Neuropathologie Raymond Escourolle, Groupe Hospitalier
Pitié-Salpêtrière, INSERM U360, Association Claude
Bernard, 75651 Paris cedex 13, France, the
Laboratoire de
Virologie, Hôpital Saint Vincent de Paul, 75674 Paris cedex 14, France, and the ** Laboratoire de Neurovirologie CEA, 92265 Fontenay aux
Roses cedex, France
We have recently described a novel mRNA
denominated ScRG-1, the level of which is increased in the
brains of Scrapie-infected mice (Dandoy-Dron, F., Guillo, F.,
Benboudjema, L., Deslys, J.-P., Lasmézas, C., Dormont, D., Tovey,
M. G., and Dron, M. (1998) J. Biol. Chem. 273, 7691-7697). The increase in ScRG-1 mRNA in the brain
follows the accumulation of PrPSc, the proteinase
K-resistant form of the prion protein (PrP), and precedes the
widespread neuronal death that occurs in late stage disease. In the
present study, we have isolated a cDNA encoding the human
counterpart of ScRG-1. Comparison of the human and mouse transcripts firmly established that both sequences encode a highly conserved protein of 98 amino acids that contains a signal peptide, suggesting that the protein may be secreted. Examination of the distribution of human ScRG-1 mRNA in adult and fetal
tissues revealed that the gene was expressed primarily in the central
nervous system as a 0.7-kilobase message and was under strict
developmental control.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.